NCT00119626View on ClinicalTrials.gov

Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

PHASE3CompletedINTERVENTIONAL

Enrollment

1,700

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions

Cerebral StrokeIschemic Attack, Transient

Interventions

DRUG

NXY-059

Trial Locations (2)

Unknown

Research Site, Södertälje

Research Site, Glasgow

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY